Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice - 16/06/19
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 12 |
| Iconographies | 8 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Highlights |
• | PSTi8 exhibits antidiabetic activity by suppressing hepatic glucose release. |
• | PSTi8 interacts with GRP78 receptor and activates its catalytic ATPase activity. |
• | Indirect calorimeter findings showed enhanced energy expenditure. |
• | PSTi8 improves lipid homeostasis and ameliorates oxidative stress. |
• | Activation of AMPK enhances insulin signalling pathway through PKC inhibition. |
Abstract |
Aims |
To investigate the role of pancreastatin inhibitor (PSTi8) in lipid homeostasis and insulin sensitivity in dexamethasone induced fatty liver disease associated type 2 diabetes.
Main methods |
Glucose releases assay, lipid O staining and ATP/AMP ratio were performed in HepG2 cells. Twenty four mice were randomly divided into 4 groups: Control group (saline), DEX (1 mg/kg, im) for 17 days, DEX+PSTi8 (acute 5 mg/kg and chronic 2 mg/kg, ip) for 10 days. The glucose, insulin and pyruvate tolerance tests (GTT, ITT and PTT), biochemical parameters and Oxymax-CLAMS were performed. Further to elucidate the action mechanisms of PSTi8, we performed genes expression and western blotting of biological samples.
Key findings |
We found that PSTi8 suppresses hepatic glucose release, lipid deposition, oxidative stress induced by DEX, stimulates the cellular energy level in hepatocytes and enhances GRP78 activity. It reduces lipogensis and enhances fatty acid oxidation to improve insulin sensitivity and glucose tolerance in DEX induced diabetic mice. The above cellular effects are the result of activated AMPK signalling pathway in liver, which increases Srebp1c and ACC phosphorylation. The increased ACC phosphorylation suppresses protein kinase C activity and enhances insulin sensitivity. The increased expression of UCP3 in liver elicits fatty acid oxidation and energy expenditure, which suppress oxidative stress.
Significance |
Thus the activation of AMPK signalling through GRP78, improves lipid homeostasis, enhances insulin sensitivity via inhibition of PKC activity. PSTi8 suppresses inflammation associated with incomplete fatty acid oxidation. Hence, PSTi8 may be a potential therapeutic agent to treat glucocorticoid-induced fatty liver associated type 2 diabetes.
Le texte complet de cet article est disponible en PDF.Abbreviations : ATP, AMP, AUC, PEPCK, FBPase, G6Pase, IRS, DEX, PST, PSTi8, LGDMEM, RER, VO2, VCO2, Srebp-1c, Fas, Acc, Cpt-1a, PGC-1α, ACOX1, AMPK, UCP3, TNF-α, NF-κB, GP, IR-β, FoxO1, GSK3β, ER, TG, IR, HOMA-IR, GT, PTT, NAFLD, VLDL, Oxymax-CLAMS, LC, DC, DCFDA
Keywords : Pancreastatin, PSTi8, Dexamethasone, Insulin resistance, GRP78, Fatty liver disease, Diabetes
Plan
Vol 116
Article 108959- août 2019 Retour au numéro
Article précédent
- Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK/ERK signaling pathway
- Lei Zhu, Lu-Ming Dai, Hong Shen, Pei-Qing Gu, Kai Zheng, Ya-Jun Liu, Lu Zhang, Jia-Fei Cheng
- Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway
- Zhigang Guo, Hu Guozhang, Hang Wang, Zhaohui Li, Naijie Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?